Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with moderate to severe Crohn's disease or Ulcerative colitis, and who started taking upadacitinib at least 12 months before joining the study — including those who later stopped taking it or switched to a different treatment
- People for whom a doctor has decided, as part of their normal medical care, to prescribe the commercially available form of upadacitinib — and where that decision was made before and separately from any involvement in this study
- People who have been prescribed upadacitinib in line with the officially approved guidelines and treatment recommendations in their country
Who may not be able to join:
- People who have previously taken upadacitinib as part of a clinical trial or an early access program
- People who are currently taking part in another interventional research study (studies that are observational only may not be affected — confirm with trial site)
- People who have a stoma (a surgically created opening in the abdomen used to redirect waste)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: ABBVIE INC., AbbVie
Phone: 844-663-3742
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants Achieving Clinical Remission as per Partial Adapted Mayo Subscores for Ulcerative Colitis; Percentage of Participants Achieving Clinical Remission as per Patient Reported Outcome (PRO2) for Crohn's Disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.